Apollomics Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Apollomics Inc.
- Ownership
- Public
- Status
- Active
- SIC code
- 2834 — Pharmaceutical Preparations
- Jurisdiction of incorporation
- Cayman Islands
- Headquarters city
- Covina
- Headquarters state / province
- California
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- APLM
- Primary stock exchange
- Nasdaq
Identifiers
- SEC CIK
- 0001944885
Board of directors
-
Chen-Huan Jan · DirectorSince 2026
-
Hong-Jung Chen · DirectorSince 2026
-
Hsien-Shu Tsai · DirectorSince 2026
-
Hung Hsien Yen · DirectorSince 2026
-
Hung-Wen Chen · Director · Chief Executive OfficerSince 2026
-
Peter Kuan-How Lin · Director · Chief Financial OfficerSince 2026
-
Ya-Chi Huang · DirectorSince 2026
-
Yi-An Chu · DirectorSince 2026
-
Yi-Kuei Chen · Director · Chief Operating OfficerSince 2026
Chief executives
Hung-Wen Chen
· Chief Executive Officer
Since March 2026
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $8,250,009
- 5 purchases by 3 insiders
- Sold, last 12 months
- $0
- 0 sales by 0 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 15, 2026 | Hung-Wen Chen Director, Officer (Chief Executive Officer), 10% owner | Option exercise | +5,000 | — | — |
| Sep 15, 2026 | Hung Hsien Yen Director | Option exercise | +500 | — | — |
| Sep 15, 2026 | Hsien-Shu Tsai Director | Option exercise | +500 | — | — |
| Sep 15, 2026 | Yi-Kuei Chen Director, Officer (Chief Operating Officer) | Option exercise | +5,000 | — | — |
| Sep 15, 2026 | Hong-Jung Chen Director | Option exercise | +500 | — | — |
| Sep 15, 2026 | Peter Kuan-How Lin Director, Officer (Chief Financial Officer) | Option exercise | +10,000 | — | — |
| Sep 15, 2026 | Peter Kuan-How Lin Director, Officer (Chief Financial Officer) | Shares withheld for tax | −3,416 | $24.02 | $82,052 |
| Aug 17, 2026 | Ya-Chi Huang Director | Option exercise | +500 | — | — |
| Aug 14, 2026 | Hung-Wen Chen Director, Officer (Chief Executive Officer) | Open-market purchase | +166,667 | $12.00 | $2,000,004 |
| Aug 14, 2026 | Peter Kuan-How Lin Officer (Chief Financial Officer) | Open-market purchase | +26,667 | $15.00 | $400,005 |
| Aug 14, 2026 | Yi-Kuei Chen Director, Officer (Chief Operating Officer) | Open-market purchase | +20,000 | $15.00 | $300,000 |
| Aug 14, 2026 | Hung-Wen Chen Director, Officer (Chief Executive Officer) | Open-market purchase | +103,333 | $15.00 | $1,549,995 |
| Aug 14, 2026 | Hung-Wen Chen Director, Officer (Chief Executive Officer) | Open-market purchase | +266,667 | $15.00 | $4,000,005 |
| Jun 15, 2026 | Peter Kuan-How Lin Director, Officer (Chief Financial Officer) | Option exercise | +10,000 | — | — |
| Jun 15, 2026 | Hung-Wen Chen Director, Officer (Chief Executive Officer) | Option exercise | +5,000 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.